| Title : Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats - Mani_2022_Pharmaceuticals.(Basel)_15_ |
| Author(s) : Mani V , Rabbani SI , Shariq A , Amirthalingam P , Arfeen M |
| Ref : Pharmaceuticals (Basel) , 15 : , 2022 |
| Abstract : Mani_2022_Pharmaceuticals.(Basel)_15_ |
| ESTHER : Mani_2022_Pharmaceuticals.(Basel)_15_ |
| PubMedSearch : Mani_2022_Pharmaceuticals.(Basel)_15_ |
| PubMedID: 36559014 |
Mani V, Rabbani SI, Shariq A, Amirthalingam P, Arfeen M (2022)
Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats
Pharmaceuticals (Basel)
15 :
Mani V, Rabbani SI, Shariq A, Amirthalingam P, Arfeen M (2022)
Pharmaceuticals (Basel)
15 :